Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Asset Writedowns and Impairment: 2009-2011

Historic Asset Writedowns and Impairment for Lexicon Pharmaceuticals (LXRX) over the last 1 years, with Dec 2011 value amounting to -$2,000.

  • Lexicon Pharmaceuticals' Asset Writedowns and Impairment fell 100.21% to -$2,000 in Q4 2011 from the same period last year, while for Dec 2011 it was $704,000, marking a year-over-year decrease of 49.64%. This contributed to the annual value of $1.6 million for FY2020, which is 94.41% down from last year.
  • Per Lexicon Pharmaceuticals' latest filing, its Asset Writedowns and Impairment stood at -$2,000 for Q4 2011, which was up 97.47% from -$79,000 recorded in Q3 2011.
  • Over the past 5 years, Lexicon Pharmaceuticals' Asset Writedowns and Impairment peaked at $951,000 during Q4 2010, and registered a low of -$79,000 during Q3 2011.
  • Moreover, its 3-year median value for Asset Writedowns and Impairment was $33,000 (2010), whereas its average is $262,750.
  • As far as peak fluctuations go, Lexicon Pharmaceuticals' Asset Writedowns and Impairment soared by 10,666.67% in 2010, and later slumped by 258.00% in 2011.
  • Lexicon Pharmaceuticals' Asset Writedowns and Impairment (Quarterly) stood at -$9,000 in 2009, then soared by 10,666.67% to $951,000 in 2010, then slumped by 100.21% to -$2,000 in 2011.
  • Its Asset Writedowns and Impairment was -$2,000 in Q4 2011, compared to -$79,000 in Q3 2011 and $16,000 in Q2 2011.